Hereditary Spherocytosis is a genetic disorder characterized by red blood cells that are fragile and spherical in shape instead of the normal flat disk shape. The abnormal shape makes it difficult for red blood cells to pass through the spleen. The spleen's function is to purify the blood and safeguard the immune function by fighting against the potentially dangerous bacteria, viruses or other microorganisms in the blood. In case of Spherocytosis, the membrane of the red blood cells is defective lending it a spherical shape. When these defective blood cells pass through the spleen, they break and destroy causing premature death of the red blood cells. The shortage of blood cells gives rise to severe anemia. It is an inherited type of Hemolytic Anemia. A parent with the disease has a 50% chance of having a child with the disease. Spherocytosis is most common in people of northern European descent.
The symptoms can vary from mild to severe. In severe cases, the disorder may be found in early childhood. In mild cases it may go unnoticed until adulthood. Patients with Spherocytosis exhibit all the symptoms associated with anemia such as fatigue, irritability, shortness of breath and muscle weakness. They also appear pale and weak. In addition to these symptoms, Spherocytosis also causes enlarged spleen and jaundice with yellow skin and eyes. Jaundice occurs due to the elevated levels of serum bilirubin as the red blood cells are destroyed within the body. Excess bilirubin, sometimes, also results in in the gallbladder. These stones may cause pain, infection or may block the tubes that lead out of the gallbladder.
Family history is checked for hereditary factor and the abdomen has to be checked for enlarged spleen. Following blood tests may be performed to support the clinical examination:
Splenectomy is the most definitive treatment for hereditary Spherocytosis. By removing the spleen, red blood cells are prevented from damage and are allowed to stay alive for a longer duration. However, removing a spleen makes the patient susceptible to infections for a lifetime. Hence patients need to take penicillin (or another antibiotic) for the rest of their lives. Immunization against pneumococcal and meningococcal infections is also prescribed. In case of severe anemia, blood transfusion is advised.
Reticulocyte Count Test
Blood is a precious fluid. Plasma, white blood corpuscles and red blood corpuscles are the three kinds of cells in the blood. The blood cells are normally made in the bone marrow. To know the level of red blood cells in the blood, reticulocyte count test is done.
Reticulocyte Count Test
Reticulocyte are immature red blood cells made by the bone marrow. Reticulocytes are in the blood for two days before developing into mature cells. Reticulocyte count test is done to determine if red blood cells are being made in the bone marrow at an appropriate rate. The count indicates how quickly reticulocytes are being produced and released by the bone marrow.
Need for Reticulocyte count test
Paleness, tiredness, weakness, shortness of breath, and/or blood in the stool are symptoms when doctors recommend Reticulocyte count test to:
Reticulocyte count test - Preparation
There isn't any specific preparation required before Reticulocyte count test. However, it is recommended to check with health care provider if any specific pre test preparation is needed. Those who have had a recent blood transfusion should inform the doctor. This can affect test results. Important information to be shared with the doctor is about medicines being taken. Women who are pregnant and mothers who are breastfeeding infants should talk to doctor before opting for the test.
Reticulocyte count test Method
The test result is available few hours after collecting blood or the next day. An elastic band is wrapped around the upper arm to stop the flow of blood. Sample of blood from the vein of the arm is taken. A drop of blood is placed on a slide, smeared, stained and is examined under a microscope. This is the manual method. Automated methods that allow for greater number of cells to be counted are most likely to replace the manual method.
Reticulocyte count test result Interpretation
The number of reticulocytes is compared to the total number of red blood corpuscles (RBC) and is reported as a percentage of reticulocytes.
Reticulocyte (%) = [Number of Reticulocytes / Number of total Red Blood Cells] X 100
In a healthy adult person, the normal range is 0.5% to 1.5%. In kids, the normal range is 3% to 6%. This is a stable percentage. The normal range may slightly vary.
High reticulocyte count suggests more red blood cells are being made by the bone marrow. This could be due to acute bleeding, chronic blood loss, hemolytic anemia, kidney disease and potentially a fatal blood disorder in the fetus or new born - erythroblastosis fetalis (Erythroblastosis Fetalis refers to a serious blood disorder in infants - Rh incompatibility disease and ABO incompatibility disease) or hemolytic disease. Also, the count increases post treatment for certain anemia like iron deficiency anemia, pernicious anemia, or folic acid deficiency anemia.
Erythroblastosis Fetalis refers to a serious blood disorder in infants - Rh incompatibility disease and ABO incompatibility disease.
Low reticulocyte count suggests fewer red blood cells are being made by the bone marrow. This can be due to aplastic anemia or iron deficiency anemia. Other instances such as exposure to radiation, a chronic infection or due to intake of certain medicines (drug toxicity) can lead to low count.
The reticulocyte count increases temporarily during pregnancy. The count is high in newborns but within few weeks the count drops to adult levels. In case the result is abnormal more tests may be administered for further analysis.
Polycythemia is a rare blood disorder in which the bone marrow produces excessive red blood cells than the usual amount and thereby thickens the blood. Polycythemia along with red blood cells may also increase white cells and platelets count. Polycythemia occurs due to a gene mutation called as JAK2V617F. The cause of this mutation is still not identified. Patients with Polycythemia condition show increased levels of hematocrit (the ratio of the volume of red blood cells to the total volume of blood) or hemoglobin (RBC count).
Primary Polycythemia is congenital and is known to occur due to a defective mechanism developed in the bone marrow. Though research is not able to pin point the exact cause of the impairment, specific gene mutation in bone marrow is said to be causing primary Polycythemia.
Secondary Polycythemia is an acquired condition, normally developed by people living in high altitude region. As these areas have poor oxygen levels, the body produces more blood cells to make up for oxygen. Smoking, lung infections, kidney tumors and cysts also lead to Polycythemia.
Symptoms of Polycythemia
Polycythemia develops gradually and may not show any symptoms initially. It may be present in the body for years and bearer may not be aware of the condition. Most often it is revealed during the blood tests carried on for some other condition. However following symptoms indicate the presence of Polycythemia:
1. Itching following a bath with warm water and redness of the skin.
2. Headache, tiredness and dizziness.
3. Breathing difficulty especially in a lying posture.
4. Enlarged spleen and bloated stomach.
5. Tingling sensation in arms and legs.
6. Excessive sweating.
Treatment of polycythemia
Polycythemia requires prompt treatment, else it may lead to blood clots and increased risk of stroke. Most often Phlebotomy (removal of small amounts of blood) is the first step in treating polycythemia. The frequency of the Phlebotomy depends upon the severity of polycythemia. Along with Phlebotomy, patient may be put on medication (hydroxyurea or anagrelide) to reduce the bone marrow ability to produce excess red blood cells. Sometimes doctor may also prescribe aspirin to prevent blood clots and aspirin will also take care of the burning sensation in the extremities.
Bibliography / Reference
Collection of Pages - Last revised Date: July 16, 2018